These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23576210)
1. Cutting-balloon angioplasty versus balloon angioplasty as treatment for short atherosclerotic lesions in the superficial femoral artery: randomized controlled trial. Poncyljusz W; Falkowski A; Safranow K; Rać M; Zawierucha D Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1500-1507. PubMed ID: 23576210 [TBL] [Abstract][Full Text] [Related]
2. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
3. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial. Amighi J; Schillinger M; Dick P; Schlager O; Sabeti S; Mlekusch W; Haumer M; Mathies R; Heinzle G; Schuster A; Loewe C; Koppensteiner R; Lammer J; Minar E; Cejna M Radiology; 2008 Apr; 247(1):267-72. PubMed ID: 18270378 [TBL] [Abstract][Full Text] [Related]
4. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Chowdhury MM; McLain AD; Twine CP Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692 [TBL] [Abstract][Full Text] [Related]
5. The role of "cutting" balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease. Cotroneo AR; Iezzi R Cardiovasc Intervent Radiol; 2010 Oct; 33(5):921-8. PubMed ID: 20098989 [TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. Aftab SA; Tay KH; Irani FG; Gong Lo RH; Gogna A; Haaland B; Tan SG; Chng SP; Pasupathy S; Choong HL; Tan BS J Vasc Interv Radiol; 2014 Feb; 25(2):190-8. PubMed ID: 24315548 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up. Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627 [TBL] [Abstract][Full Text] [Related]
8. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR; J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193 [TBL] [Abstract][Full Text] [Related]
9. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972 [TBL] [Abstract][Full Text] [Related]
10. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis. Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527 [TBL] [Abstract][Full Text] [Related]